Cite Filings / HOWL / 0001609492-26-000006

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

Werewolf Therapeutics, Inc. Filed 2026-05-12 Acc 0001609492-26-000006

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

2026-05-14 SCHEDULE 13D/A Beneficial Ownership Report
2026-05-12 SCHEDULE 13D/A Beneficial Ownership Report
2026-05-12 4 10% owner sold 565,167 shares at an average $0.69 ($390,688)
2026-05-12 4 Director sold 407,574 shares at an average $0.69 ($280,210)
2026-05-11 144 Sale of Securities
2026-05-11 144 Sale of Securities
2026-05-05 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…